High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus

Objective. Long noncoding RNA (lncRNA) and circular RNA (circRNA) are receiving increasing attention in diabetes research. However, there are still many unknown lncRNAs and circRNAs that need further study. The aim of this study is to identify new lncRNAs and circRNAs and their potential biological...

Full description

Bibliographic Details
Main Authors: Fang Yang, Yang Chen, Zhiqiang Xue, Yaogai Lv, Li Shen, Kexin Li, Pingping Zheng, Pan Pan, Tianyu Feng, Lina Jin, Yan Yao
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/8162524
id doaj-2a5075023cd44637b09920db8a1fae78
record_format Article
spelling doaj-2a5075023cd44637b09920db8a1fae782020-11-25T03:24:13ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/81625248162524High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes MellitusFang Yang0Yang Chen1Zhiqiang Xue2Yaogai Lv3Li Shen4Kexin Li5Pingping Zheng6Pan Pan7Tianyu Feng8Lina Jin9Yan Yao10Department of Health Management Center, the First Hospital of Jilin University, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaDepartment of Epidemiology and Statistics, School of Public Health, Xinjiang Medical University, Urumqi, 830011, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaDepartment of Hospital Infection Management, Zhengzhou People’s Hospital, Zhengzhou, Henan, 450000, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaEpidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, 130021, ChinaObjective. Long noncoding RNA (lncRNA) and circular RNA (circRNA) are receiving increasing attention in diabetes research. However, there are still many unknown lncRNAs and circRNAs that need further study. The aim of this study is to identify new lncRNAs and circRNAs and their potential biological functions in type 2 diabetes mellitus (T2DM). Methods. RNA sequencing and differential expression analysis were used to identify the noncoding RNAs (ncRNAs) and mRNAs that were expressed abnormally between the T2DM and control groups. The competitive endogenous RNA (ceRNA) regulatory network revealed the mechanism of lncRNA and circRNA coregulating gene expression. The biological functions of lncRNA and circRNA were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The candidate hub mRNAs were selected by the protein-protein interaction (PPI) network and validated by using the Gene Expression Omnibus (GEO) database. Results. Differential expression analysis results showed that 441 lncRNAs (366 upregulated and 75 downregulated), 683 circRNAs (354 upregulated and 329 downregulated), 93 miRNAs (63 upregulated and 30 downregulated), and 2923 mRNAs (1156 upregulated and 1779 downregulated) were identified as remarkably differentially expressed in the T2DM group. The ceRNA regulatory network showed that a single lncRNA and circRNA can be associated with multiple miRNAs, and then, they coregulate more mRNAs. Functional analysis showed that differentially expressed lncRNA (DElncRNA) and differentially expressed circRNA (DEcircRNA) may play important roles in the mTOR signaling pathway, lysosomal pathway, apoptosis pathway, and tuberculosis pathway. In addition, PIK3R5, AKT2, and CLTA were hub mRNAs screened out that were enriched in an important pathway by establishing the PPI network. Conclusions. This study is the first study to explore the molecular mechanisms of lncRNA and circRNA in T2DM through the ceRNA network cofounded by lncRNA and circRNA. Our study provides a novel insight into the T2DM from the ceRNA regulatory network.http://dx.doi.org/10.1155/2020/8162524
collection DOAJ
language English
format Article
sources DOAJ
author Fang Yang
Yang Chen
Zhiqiang Xue
Yaogai Lv
Li Shen
Kexin Li
Pingping Zheng
Pan Pan
Tianyu Feng
Lina Jin
Yan Yao
spellingShingle Fang Yang
Yang Chen
Zhiqiang Xue
Yaogai Lv
Li Shen
Kexin Li
Pingping Zheng
Pan Pan
Tianyu Feng
Lina Jin
Yan Yao
High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
BioMed Research International
author_facet Fang Yang
Yang Chen
Zhiqiang Xue
Yaogai Lv
Li Shen
Kexin Li
Pingping Zheng
Pan Pan
Tianyu Feng
Lina Jin
Yan Yao
author_sort Fang Yang
title High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
title_short High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
title_full High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
title_fullStr High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
title_full_unstemmed High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus
title_sort high-throughput sequencing and exploration of the lncrna-circrna-mirna-mrna network in type 2 diabetes mellitus
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description Objective. Long noncoding RNA (lncRNA) and circular RNA (circRNA) are receiving increasing attention in diabetes research. However, there are still many unknown lncRNAs and circRNAs that need further study. The aim of this study is to identify new lncRNAs and circRNAs and their potential biological functions in type 2 diabetes mellitus (T2DM). Methods. RNA sequencing and differential expression analysis were used to identify the noncoding RNAs (ncRNAs) and mRNAs that were expressed abnormally between the T2DM and control groups. The competitive endogenous RNA (ceRNA) regulatory network revealed the mechanism of lncRNA and circRNA coregulating gene expression. The biological functions of lncRNA and circRNA were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The candidate hub mRNAs were selected by the protein-protein interaction (PPI) network and validated by using the Gene Expression Omnibus (GEO) database. Results. Differential expression analysis results showed that 441 lncRNAs (366 upregulated and 75 downregulated), 683 circRNAs (354 upregulated and 329 downregulated), 93 miRNAs (63 upregulated and 30 downregulated), and 2923 mRNAs (1156 upregulated and 1779 downregulated) were identified as remarkably differentially expressed in the T2DM group. The ceRNA regulatory network showed that a single lncRNA and circRNA can be associated with multiple miRNAs, and then, they coregulate more mRNAs. Functional analysis showed that differentially expressed lncRNA (DElncRNA) and differentially expressed circRNA (DEcircRNA) may play important roles in the mTOR signaling pathway, lysosomal pathway, apoptosis pathway, and tuberculosis pathway. In addition, PIK3R5, AKT2, and CLTA were hub mRNAs screened out that were enriched in an important pathway by establishing the PPI network. Conclusions. This study is the first study to explore the molecular mechanisms of lncRNA and circRNA in T2DM through the ceRNA network cofounded by lncRNA and circRNA. Our study provides a novel insight into the T2DM from the ceRNA regulatory network.
url http://dx.doi.org/10.1155/2020/8162524
work_keys_str_mv AT fangyang highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT yangchen highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT zhiqiangxue highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT yaogailv highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT lishen highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT kexinli highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT pingpingzheng highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT panpan highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT tianyufeng highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT linajin highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
AT yanyao highthroughputsequencingandexplorationofthelncrnacircrnamirnamrnanetworkintype2diabetesmellitus
_version_ 1715225942854467584